Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature

Immune-checkpoint inhibitors (ICIs) are the most effective treatments nowadays. Nivolumab was the second ICI used for treating solid tumors with amazing results. Patients treated with Nivolumab may react differently to this treatment. Some people tolerate this treatment very well without experiencin...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Cristina-Florina Pîrlog, Andreea Ioana Paroșanu, Cristina Orlov Slavu, Mihaela Olaru, Ana Maria Popa, Cristian Iaciu, Irina Niță, Pompilia Moțatu, Cotan Horia, Loredana Sabina Cornelia Manolescu, Cornelia Nițipir
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	Nivolumab hypersensitivity reaction immune-checkpoint inhibitors
Online Access:	https://www.mdpi.com/1718-7729/29/12/741